Fumaric Acid

Fumaric Acid

SCHEMBL9760768

COC(=O)C1=C(C)NC(COCCOCCN)=C(C(=O)OCC(C)C)[C@@H]1c1cccc(Cl)c1Cl.O=C(O)C=CC(=O)O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C known ✓ Q13936 9/20 0.63
ADRA1A known ✓ P35348 4/20 0.63
SLC6A3 known ✓ Q01959 3/20 0.63
KCNH2 known ✓ Q12809 3/20 0.63
HTR1A known ✓ P08908 2/20 0.63
ADRA2A known ✓ P08913 2/20 0.63
DRD1 known ✓ P21728 2/20 0.63
SLC6A2 known ✓ P23975 2/20 0.63
HTR2B known ✓ P41595 2/20 0.63
ADRB2 known ✓ P07550 1/20 0.63
DRD2 known ✓ P14416 1/20 0.63
ADRA2C known ✓ P18825 1/20 0.63
ADRA1D known ✓ P25100 1/20 0.63
HTR2A known ✓ P28223 1/20 0.63
HTR2C known ✓ P28335 1/20 0.63
ADRA1B known ✓ P35368 1/20 0.63
MEN1 known ✓ O00255 2/20 0.54
KMT2A known ✓ Q03164 2/20 0.54
MTOR known ✓ P42345 1/20 0.54
CACNA1F known ✓ O60840 8/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9760752 1.00 CACNA1C (0.63) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL10569551 0.95 CACNA1C (0.69) CACNA1CADRA1AABCB11TBXA2RSLC6A3
SCHEMBL10569548 0.95 CACNA1C (0.69) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Olradipine SCHEMBL9759987 0.92 TBXA2R (0.75) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Olradipine SCHEMBL9759998 0.92 TBXA2R (0.75) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Fumaric Acid SCHEMBL9761229 0.91 CACNA1C (0.57) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Fumaric Acid SCHEMBL9761213 0.91 CACNA1C (0.57) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Fumaric Acid SCHEMBL9761314 0.91 TBXA2R (0.61) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Fumaric Acid SCHEMBL9761329 0.91 TBXA2R (0.61) CACNA1CADRA1AABCB11TBXA2RSLC6A3
Fumaric Acid SCHEMBL9760186 0.89 TBXA2R (0.62) CACNA1CADRA1AABCB11TBXA2RSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026863-A Medicinal products in racemic or enantiomorph form; calcium channel blockers. hypotensive agents, cardiovascular disorders ADIR ET COMPAGNIE (FR) 1991-06-25 US disclosed
US-4983740-A Multistep; from 2- 2-/2-chloroethoxy/ethoxy!ethanol and potassium phthalimide ADIR ET COMPAGNIE (FR) 1991-01-08 US disclosed
US-4870091-A CALCIUM CHANNEL BLOCKERS ADIR ET CIE (FR) 1989-09-26 US disclosed